Enliven Therapeutics

Enliven Therapeutics

Discovering and developing next generation precision oncology therapeutics.

HQ location
Boulder, United States
Launch date
Employees
Market cap
$1.2b
Enterprise value
$930m
Share price
$20.06 ELVN
Recent deals
Authorizing premium user...